EU IVDR: Risk Of Noncompliance Is A Real Threat Under Current Deadline Pressures
Executive Summary
Cries for the EU to pay more attention to IVDs are growing louder by the day. It is feared the EU IVD sector is heading for a crisis and safe products will have to be pulled from the market.
You may also be interested in...
European Commission ‘Will Not Delay IVDR, Nor MDR Any Further’
It seems that the medical device and IVD industries are clutching at straws if they expect the European Commission to agree to further delays in the EU medtech regulations.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.